Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 7.7T | 6.9T | 7.1T | 7.0T |
Cost of revenue | 1.8T | 1.6T | 1.6T | 1.8T |
Gross profit | 6.0T | 5.3T | 5.5T | 5.2T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.0T | 934.4B | 1.3T | 994.1B |
Other operating expenses | — | — | — | — |
Operating income | 4.7T | 4.1T | 4.0T | 4.0T |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 184.8B | 172.5B | 174.4B | 150.7B |
Other income expense | -44.5B | -83.4B | -150.7B | -162.0B |
Pretax income | 4.4T | 3.8T | 3.7T | 3.7T |
Tax provision | 920.2B | 711.7B | 520.3B | 571.4B |
Net income | 3.5T | 3.1T | 3.2T | 3.1T |
Basic EPS | 4.1 | 3.6 | 3.6 | 3.5 |
Diluted EPS | 4.1 | 3.6 | 3.6 | 3.5 |
Basic average shares | 860.5B | 864.3B | 869.0B | 874.7B |
Diluted average shares | 861.4B | 866.2B | 870.9B | 876.6B |
EBITDA | 4.9T | 4.3T | 4.2T | 4.2T |
Net income from continuing op. | 3.5T | 3.1T | 3.2T | 3.1T |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |